PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Omeprazole attenuates cisplatin-induced kidney injury through suppression of the TLR4/NF-kappaB/NLRP3 signaling pathway.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32418911 ↗2020Reported benefit

Omeprazole attenuates cisplatin-induced kidney injury through suppression of the TLR4/NF-kappaB/NLRP3 signaling pathway.

RatChemical/toxinSprague-DawleyMalen = n = 10 per group, five groupsIntraperitoneal1.8 or 3.6 mg/kg body weightPretreatment for 5 days, with the final dose 1 h before cisplatin

Model: Cisplatin-induced acute kidney injury (15 mg/kg cisplatin intraperitoneally)

Omeprazole reduced cisplatin-induced apoptosis and structural kidney damage in vivo and in vitro and inhibited TLR4/NF-kappaB/NLRP3 signalling; the anti-inflammatory effect was blunted by LPS co-treatment in HK-2 cells.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.